Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Upadacitinib may effectively treat alopecia areata without side effects.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Ruxolitinib can cause a delayed skin reaction on the nose.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Promising cancer treatments were found, but the manufacturer closed.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Tofacitinib might be used to treat hair loss.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.